Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

Journal of Urology

Volumn 177, Issue 1, 2007, Pages 107-112

  Steyerberg, E W ^a   Roobol, M J ^a   Kattan, M W ^b   van der Kwast, T H ^a   de Koning, H J ^a   Schroder F H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

biopsy; models; prognosis; prostate; prostatic neoplasms; statistical

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; GLEASON SCORE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

AGED; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33845313601     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.068     Document Type: Article

References (20)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74
2. von Eschenbach A.C. The biologic dilemma of early carcinoma of the prostate. Cancer 78 (1996) 326
3. Johansson J.E., Andren O., Andersson S.O., Dickman P.W., Holmberg L., Magnuson A., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713
4. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368
5. Carter H.B., Sauvageot J., Walsh P.C., and Epstein J.I. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. J Urol 157 (1997) 2206
6. Goto Y., Ohori M., Arakawa A., Kattan M.W., Wheeler T.M., and Scardino P.T. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 156 (1996) 1059
7. Kattan M.W., Eastham J.A., Wheeler T.M., Maru N., Scardino P.T., Erbersdobler A., et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 170 (2003) 1792
8. Schroder F.H. Prostate cancer: to screen or not to screen?. BMJ 306 (1993) 407
9. deKoning H.J., Liem M.K., Baan C.A., Boer R., Schroder F.H., and Alexander F.E. Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial. Int J Cancer 98 (2002) 268
10. Roobol M.J., Kirkels W.J., and Schroder F.H. Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands). BJU Int 92 suppl (2003) 48
11. Hoedemaeker R.F., Rietbergen J.B., Kranse R., Schroder F.H., and van der Kwast T.H. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. J Urol 164 (2000) 411
12. Cox D.R. Two further applications of a model for binary regression. Biometrika 45 (1958) 562
13. Steyerberg E.W., Eijkemans M.J., Harrell Jr. F.E., and Habbema J.D. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19 (2000) 1059
14. Steyerberg E.W., Borsboom G.J., VanHouwelingen H.C., Eijkemans M.J., and Habbema J.D. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med 23 (2004) 2567
15. Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 19 (2000) 1831
16. vanderKwast T.H., Ciatto S., Martikainen P.M., Hoedemaeker R., Laurila M., Pihl C.G., et al. Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer. Int J Cancer 118 (2005) 2538
17. Kattan M.W. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 95 (2003) 634
18. Klotz L. Active surveillance with selective delayed intervention: using natural history to guide treatment in good risk prostate cancer. J Urol 172 (2004) S48
19. Patel M.I., DeConcini D.T., Lopez-Corona E., Ohori M., Wheeler T., and Scardino P.T. An analysis of men with clinically localized prostate cancer who deferred definitive therapy. J Urol 171 (2004) 1520
20. Ross P.L., Scardino P.T., and Kattan M.W. A catalog of prostate cancer nomograms. J Urol 165 (2001) 1562